2017 Onco-Nephrology Symposium

2017 Onco-Nephrology Symposium Banner

Date & Location
Friday, December 1, 2017, 7:30 AM - 6:00 PM, Zuckerman Research Center 417 E 68th St, New York, NY

Target Audience
Hospital Medicine, Internal Medicine , Medical Oncology, Nephrology


Cancer patients present the nephrologist with more complex fluid and electrolyte disturbances than those typically encountered, and the introduction of novel anti-cancer drugs with fairly unique toxicities has created the need for specialized education in the field of onco-nephrology. This seminar will enable participants to advance and refine their understanding of unique issues relating to the evaluation and management of patients with cancer with acquired and chronic kidney disease. Didactic lectures will focus on electrolyte derangements in cancer patients, targeted therapies and their nephrotoxic effects, recognition and management of monoclonal gammopathy of renal significance, acute and chronic kidney disease in the bone marrow transplant patient, anemia management in cancer patients, and care of the renal transplant patient with cancer. Participants will learn about common urinary diversion procedures in these patients and their related complications. Additionally attendees will participate in clinicopathologic case presentations. 

This course is directly provided by Memorial Sloan Kettering and in collaboration with MD Anderson Cancer Center.

This course is endorsed by the American Society of Nephrology (ASN) and the International Society of Nephrology (ISN).

Target Audience
This course is intended for physicians and healthcare professionals in Hospital Medicine, Internal Medicine, Nephrology and Oncology.


Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants or financial support for this live activity:

  • Novartis
  • Relypsa, Inc.

  1. Recognize the clinical and laboratory features of the variety of sodium disorders in cancer patients
  2. Identify the clinical and laboratory features of renal toxicities across a spectrum of cancer chemotherapies
  3. Identify the clinical and laboratory features of monoclonal gammopathy of renal significance
  4. Manage specific categories of patients with AKI or CKD including bone marrow transplant patients and renal transplants patients diagnosed with cancer
  5. Evaluate and manage the patient with a renal mass or renal cancer
  6. Understand the differences among various urinary diversion procedures and the fluid and electrolyte disorders associated with them


Physicians (MDs, PhDs and DOs)  $325 
Fellows, Residents, Nurses and Other Healthcare Providers     $150 
Industry Members*  $575 

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration Details

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact us at least one week prior to the course if you have any special dietary needs.

  • 30% Discounted Rate for MSK Alumni and MSK Alliance Members 
    MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact cme@mskcc.org for more information or to register.
  • MSK Staff Registration 
    Registration is complimentary for MSK staff. However, you must complete course registration to attend this course. 

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course (cme@mskcc.org).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.


Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.75 Medical Knowledge MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

CE Credits

This course will not offer nursing CE credits. Nurses will receive a non-physician CME certificate for AMA PRA Category 1 Credit(s)™.  Certain nursing certification providers (such as ANCC) may accept this certificate for CE requirements. Please check with your certification providers for more information.